Proton pump inhibitors do not affect risk for Clostridium difficile infection in the intensive care unit

od Faleck, David M., Salmasian, Hojjat, Furuya, E. Yoko, Larson, Elaine L., Abrams, Julian A., Freedberg, Daniel E.
Wydane w Am J Gastroenterol (2016)

Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: A multicenter study

od Adar, Tomer, Faleck, David M., Sasidharan, Saranya, Cushing, Kelly, Borren, Nienke Z, Nalagatla, Niharika, Ungaro, Ryan C., Wayne, Sy, Samuel C, Owen, Patel, Anish, Cohen, Benjamin L., Ananthakrishnan, Ashwin N
Wydane w Aliment Pharmacol Ther (2019)

Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis

od Choy, Matthew C, Seah, Dean, Faleck, David M, Shah, Shailja C, Chao, Che-Yung, An, Yoon-Kyo, Radford-Smith, Graham, Bessissow, Talat, Dubinsky, Marla C, Ford, Alexander C, Churilov, Leonid, Yeomans, Neville D, De Cruz, Peter P
Wydane w Inflamm Bowel Dis (2019)

Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease

od Abu-Sbeih, Hamzah, Faleck, David M., Ricciuti, Biagio, Mendelsohn, Robin B., Naqash, Abdul R., Cohen, Justine V., Sellers, Maclean C., Balaji, Aanika, Ben-Betzalel, Guy, Hajir, Ibraheim, Zhang, Jiajia, Awad, Mark M., Leonardi, Giulia C., Johnson, Douglas B., Pinato, David J., Owen, Dwight H., Weiss, Sarah A., Lamberti, Giuseppe, Lythgoe, Mark P., Manuzzi, Lisa, Arnold, Christina, Qiao, Wei, Naidoo, Jarushka, Markel, Gal, Powell, Nick, Yeung, Sai-Ching J., Sharon, Elad, Dougan, Michael, Wang, Yinghong
Wydane w J Clin Oncol (2020)

Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes

od Koliani-Pace, Jenna L, Singh, Siddharth, Luo, Michelle, Hirten, Robert, Aniwan, Satimai, Kochhar, Gursimran, Chang, Shannon, Lukin, Dana, Gao, Youran, Bohm, Matthew, Swaminath, Arun, Gupta, Nitin, Shmidt, Eugenia, Meserve, Joseph, Winters, Adam, Chablaney, Shreya, Faleck, David M, Yang, Jiao, Huang, Zhongwen, Boland, Brigid S, Shashi, Preeti, Weiss, Aaron, Hudesman, David, Varma, Sashidhar, Fischer, Monika, Sultan, Keith, Shen, Bo, Kane, Sunanda, Loftus, Edward V, Sands, Bruce E, Colombel, Jean-Frederic, Sandborn, William J, Lasch, Karen, Siegel, Corey A, Dulai, Parambir S
Wydane w Inflamm Bowel Dis (2019)

Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis

od Faleck, David M., Winters, Adam, Chablaney, Shreya, Shashi, Preeti, Meserve, Joseph, Weiss, Aaron, Aniwan, Satimai, Koliani-Pace, Jenna L., Kochhar, Gursimran, Boland, Brigid S., Singh, Siddharth, Hirten, Robert, Shmidt, Eugenia, Kesar, Varun, Lasch, Karen, Luo, Michelle, Bohm, Matthew, Varma, Sashidhar, Fischer, Monika, Hudesman, David, Chang, Shannon, Lukin, Dana, Sultan, Keith, Swaminath, Arun, Gupta, Nitin, Siegel, Corey A., Shen, Bo, Sandborn, William J., Kane, Sunanda, Loftus, Edward V., Sands, Bruce E., Colombel, Jean-Frederic, Dulai, Parambir S., Ungaro, Ryan
Wydane w Clin Gastroenterol Hepatol (2019)